Chris A Liacouras
Overview
Explore the profile of Chris A Liacouras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
4316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strauss Starling A, Ren Y, Li H, Spergel J, Muir A, Lynch K, et al.
Am J Gastroenterol
. 2024 Apr;
119(10):2002-2009.
PMID: 38661151
Introduction: There are limited longitudinal data on the impact of chronic therapy on the natural history of eosinophilic esophagitis (EoE), a chronic allergic disease of the esophagus. The purpose of...
2.
Bauer M, Nguyen N, Liacouras C
Immunol Allergy Clin North Am
. 2024 Apr;
44(2):157-171.
PMID: 38575215
The diagnosis of eosinophilic esophagitis (EoE) is based on clinical symptoms of esophageal dysfunction and eosinophil predominant esophageal inflammation. Clinical symptoms in children with EoE vary based on age and...
3.
Aceves S, Dellon E, Greenhawt M, Hirano I, Liacouras C, Spergel J
Ann Allergy Asthma Immunol
. 2022 Dec;
130(3):371-378.
PMID: 36521784
The Joint Task Force for the American Academy of Allergy Asthma Immunology and American College of Allergy Asthma Immunology and the American Gastroenterology Association recently published guidelines for the management...
4.
Dellon E, Khoury P, Muir A, Liacouras C, Safroneeva E, Atkins D, et al.
Gastroenterology
. 2022 May;
163(1):59-76.
PMID: 35606197
Background & Aims: Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic options and management, but the decision-making process for determining severity varies among practitioners. To reduce variability in...
5.
Dellon E, Khoury P, Muir A, Liacouras C, Safroneeva E, Atkins D, et al.
J Allergy Clin Immunol
. 2022 May;
150(1):33-47.
PMID: 35606166
Background & Aims: Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic options and management, but the decision-making process for determining severity varies among practitioners. To reduce variability in...
6.
Dellon E, Gonsalves N, Abonia J, Alexander J, Arva N, Atkins D, et al.
Clin Gastroenterol Hepatol
. 2022 Feb;
20(11):2474-2484.e3.
PMID: 35181570
Background & Aims: Substantial heterogeneity in terminology used for eosinophilic gastrointestinal diseases (EGIDs), particularly the catchall term "eosinophilic gastroenteritis," limits clinical and research advances. We aimed to achieve an international...
7.
Spergel B, Ruffner M, Godwin B, Liacouras C, Cianferoni A, Gober L, et al.
Ann Allergy Asthma Immunol
. 2022 Jan;
128(5):589-593.
PMID: 35085819
Background: Dupilumab has been approved to treat atopic dermatitis, asthma, and nasal polyps and is in active clinical trials for the treatment of eosinophilic esophagitis (EoE). Given its shared immunopathology,...
8.
Spergel J, Muir A, Liacouras C, Burke D, Lewis M, Brown-Whitehorn T, et al.
Allergy
. 2020 Nov;
76(5):1573-1576.
PMID: 33202086
No abstract available.
9.
Spergel J, Brown-Whitehorn T, Muir A, Liacouras C
Allergy
. 2020 Jan;
75(6):1522-1524.
PMID: 31953959
No abstract available.
10.
Whelan K, Godwin B, Wilkins B, Elci O, Benitez A, DeMarshall M, et al.
Clin Gastroenterol Hepatol
. 2019 Sep;
18(7):1475-1482.e1.
PMID: 31499251
Background & Aims: Although eosinophil count is the standard used to monitor disease activity in patients with eosinophilic esophagitis (EoE), there are often disparities between patient-reported symptoms and eosinophil counts....